Suchergebnisse - "Cariou, Bertrand"

PubPharm (6)

1

Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity : A Post Hoc Analysis of the SUSTAIN Trials

enthalten in: The Journal of clinical endocrinology and metabolism | 2020

von DeSouza, C. | Cariou, B. | Garg, S. | +3

2

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes

enthalten in: Cardiovascular diabetology | 2017

von Orchard, T. | Cariou, B. | Connelly, M. | +5

3

Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4) : a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial

enthalten in: The lancet. Diabetes & endocrinology | 2017

von Aroda, V. | Bain, S. | Cariou, B. | +5

CommentIn: Lancet Diabetes Endocrinol. 2017 May;5(5):315-317. - PMID 28385658

4

Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials

enthalten in: Diabetes, obesity & metabolism | 2016

von Ginsberg, H. | Cariou, B. | Orchard, T. | +8

5

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes : a 2-year randomized, treat-to-target trial

enthalten in: Diabetic medicine : a journal of the British Diabetic Association | 2013

von Rodbard, H. | Cariou, B. | Zinman, B. | +106

CommentIn: Diabet Med. 2013 Nov;30(11):1267. - PMID 24134602

6

Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes : a 1-year, randomized, treat-to-target trial (BEGIN Once Long)

enthalten in: Diabetes care | 2012

von Zinman, B. | Philis-Tsimikas, A. | Cariou, B. | +6

1
[1]